Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011854 (type 1 diabetes)
 20,749 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A prospective study on the effect of ECCE + IOL implantation on the course of diabetic retinopathy (DR) in 59 eyes showed that in one to three years following surgery, progression of DR, including the development of newly formed one, occurred in 28.8% of the eyes. This was more marked in patient with IDDM (IDDM-46%, NIDDM-24%) as well as in eyes with pre-operative BDR (pre-operative BDR-62.5%, no pre-operative BDR-16.3%). Final visual acuity was better in eyes without pre-operative DR as well as in eyes that did not show progression of the retinopathy.
 ...
PMID:The course of nonproliferative diabetic retinopathy following ECCE with posterior chamber IOL implantation. 871 79

The knowing of the ocular consequences of diabetes is essential for the evaluation of the risk factors for the cataract surgery. The clinical study was made on a total number of 19 diabetic patients (3 with insulin dependent diabetes and the rest with noninsulin dependent diabetes), which were operated for cataract from september 2001 till march 2002. Preoperatory preparation presumed a good metabolic control of diabetes and a very carefully examination of the retina. The surgical technique was the extracapsular cataract extraction, followed by the implantation of a posterior chamber IOL, respectively phacoemulsification with the implantation of a foldable lens. The presence of a proliferative diabetic retinopathy, of a rubeosis iridis, of the neovascularization of the angle, or the preexistence of the vitreoretinal surgery (vitrectomy) were the main factors which dictated the anatomical and functional postoperatory prognosis. In conclusion, evenly the diabetic patient is a highly risk patient, the adequate preoperator preparation, the right treatment and a carefully follow-up could assure the success of the surgery in those cases.
 ...
PMID:[Particular aspects of treatment in diabetic eye cataract]. 1272 95